A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

por Santos, José R, Domingo, Pere, Portilla, Joaquín, Gutiérrez, Félix, Imaz, Arkaitz, Vilchez, Helem, Curran, Adrià, Valcarce-Pardeiro, Nieves, Payeras, Antoni, Bernal, Enrique, Montero-Alonso, Marta, Yzusqui, Miguel, Clotet, Bonaventura, Videla, Sebastià, Moltó, José, Paredes, Roger
Publicado 2023